Published in J Pharmacol Exp Ther on August 01, 1978
Urinary and brain beta-carboline-3-carboxylates as potent inhibitors of brain benzodiazepine receptors. Proc Natl Acad Sci U S A (1980) 1.25
Benzodiazepines that bind at peripheral sites inhibit cell proliferation. Proc Natl Acad Sci U S A (1984) 1.22
The binding of [3H]-diazepam to guinea-pig ileal longitudinal muscle and the in vitro inhibition of contraction by benzodiazepines. Br J Pharmacol (1983) 0.95
Benzodiazepine receptors increase in post-mortem brain of chronic schizophrenics. Eur Arch Psychiatry Neurol Sci (1989) 0.78
Loperamide binding to opiate receptor sites of brain and myenteric plexus. J Pharmacol Exp Ther (1976) 1.06
32P analysis of DNA adducts in tissues of benzene-treated rats. Environ Health Perspect (1989) 1.05
Oxidation and phosphorylation in live mitochondria from alloxan and steptozotocin diabetic rats. Proc Soc Exp Biol Med (1971) 0.92
A method for in vitro culture of rat Zymbal gland: use in mechanistic studies of benzene carcinogenesis in combination with 32P-postlabeling. Environ Health Perspect (1989) 0.88
Interaction of loperamide with [3H]naloxone binding sites in guinea pig brain and myenteric plexus. Mol Pharmacol (1977) 0.85
Effect of sub-acute administration of clofibrate on the oxidation of fatty acids by liver mitochondria. Biochem Pharmacol (1977) 0.85
An automated myeloperoxidase assay. Clin Chem (1990) 0.84
In vitro and in vivo percutaneous absorption of benzo[a]pyrene from petroleum crude-fortified soil in the rat. Bull Environ Contam Toxicol (1989) 0.84
pH effects on oxidative phosphorylation of rat liver mitochondria. Am J Physiol (1972) 0.82
Effects of clofibrate, in vitro, on mitochondrial respiration and oxidative phosphorylation. Biochem Pharmacol (1973) 0.81
Health effects of the alkylbenzenes. I. Toluene. Toxicol Ind Health (1988) 0.81
SAR models for estimating the percutaneous absorption of polynuclear aromatic hydrocarbons. SAR QSAR Environ Res (1998) 0.80
Lack of DNA adduct formation in mice treated with benzene. Mutat Res (1994) 0.80
Health effects of the alkylbenzenes. II. Xylenes. Toxicol Ind Health (1989) 0.80
Correlation of mutagenic and dermal carcinogenic activities of mineral oils with polycyclic aromatic compound content. Fundam Appl Toxicol (1988) 0.80
Percutaneous and oral absorption of chlorinated paraffins in the rat. Toxicol Ind Health (1987) 0.78
Further studies concerning the effects of clofibrate on respiration and oxidative phosphorylation of rat liver mitochondria. Biochem Pharmacol (1974) 0.78
Developmental toxicity of dermally applied crude oils in rats. J Toxicol Environ Health (1997) 0.78
Percutaneous absorption of benzo[a]pyrene in the rat: comparison of in vivo and in vitro results. Toxicol Ind Health (1986) 0.78
Percutaneous absorption of anthracene in the rat: comparison of in vivo and in vitro results. Toxicol Ind Health (1986) 0.78
Aging does not alter the sensitivity of benzodiazepine receptors to GABA modulation. Neurobiol Aging (1987) 0.77
A double-blind, placebo-controlled, 6-day evaluation of two doses of misoprostol in gastroduodenal mucosal protection against damage from aspirin and effect on bowel habits. Am J Gastroenterol (1991) 0.77
DNA adduction by phenol, hydroquinone, or benzoquinone in vitro but not in vivo: nuclease P1-enhanced 32P-postlabeling of adducts as labeled nucleoside bisphosphates, dinucleotides and nucleoside monophosphates. Carcinogenesis (1990) 0.77
Antiestrogenicity of clarified slurry oil and two crude oils in a human breast-cancer cell assay. J Toxicol Environ Health A (2001) 0.77
Benzene induces a dose-responsive increase in the frequency of micronucleated cells in rat Zymbal glands. Environ Health Perspect (1996) 0.76
Pharmacokinetics and metabolism of benzene in Zymbal gland and other key target tissues after oral administration in rats. Environ Health Perspect (1989) 0.76
Use of a surrogate aerosol in a preliminary screening for the potential carcinogenicity of coal coated with No. 6 fuel oil. Am Ind Hyg Assoc J (1998) 0.76
Antidiarrheal and central nervous system activities of SC-27166 (2-[3 - 5 - methyl - 1, 3, 4 - oxadiazol - 2 - yl) - 3, 3 - diphenylpropyl] - 2 - azabicyclo [2.2.2]octane), a new antidiarrheal agent, resulting from binding to opiate receptor sites of brain and myenteric plexus. J Pharmacol Exp Ther (1977) 0.76
Heterogeneity of brain benzodiazepine receptors demonstrated by [3H]propyl beta-carboline-3-carboxylate binding. Mol Pharmacol (1982) 0.76
Current status of benzene teratology: a brief review. J Environ Pathol Toxicol (1980) 0.76
Stress ulcers and organ failure in intubated patients in surgical intensive care units. Ann Surg (1992) 0.75
Alpha-oxoglutarate carboxylation in rat kidney mitochondria. Proc Soc Exp Biol Med (1972) 0.75
Renal gluconeogenesis in clofibrate-treated rats. J Pharmacol Exp Ther (1978) 0.75
Ion-pair reverse phase liquid chromatographic determination of sodium acifluorfen in feed. J Assoc Off Anal Chem (1983) 0.75
-Oxoglutarate carboxylation in liver mitochondria from normal, alloxan diabetic and streptozotocin diabetic rats. Proc Soc Exp Biol Med (1972) 0.75
Synthesis of beta-spiro[pyrrolidinoindolines], their binding to the glycine receptor, and in vivo biological acitivity. J Med Chem (1977) 0.75
The binding of strychnine and strychnine analogs to synaptic membranes of rat brainstem and spinal cord. J Pharmacol Exp Ther (1977) 0.75
Calcium alters divalent cation modulation of brain benzodiazepine receptors. Arch Int Pharmacodyn Ther (1983) 0.75
Alpha-oxoglutarate carboxylation in liver mitochondria isolated from rats fed diets of varied fat concentration. 1. Proc Soc Exp Biol Med (1972) 0.75
Evaluation of the EYTEX system as a screen for eye irritancy of petroleum products. Toxicol In Vitro (1994) 0.75
Developmental toxicity of clarified slurry oil, syntower bottoms, and distillate aromatic extract administered as a single oral dose to pregnant rats. J Toxicol Environ Health (1996) 0.75
Assessment of diabetogenic drug activity in the rat: diphenylhydantoin. J Toxicol Environ Health (1976) 0.75
Enhancement of renal gluconeogenesis by clofibrate. Biochem Pharmacol (1978) 0.75
Assessment in rats of the reproductive toxicity of gasoline from a gasoline vapor recovery unit. Reprod Toxicol (2000) 0.75
Systemic and developmental toxicity of dermally applied distillate aromatic extract in rats. Fundam Appl Toxicol (1996) 0.75
Developmental toxicity study in rats exposed dermally to clarified slurry oil for a limited period of gestation. J Toxicol Environ Health (1996) 0.75
Thermodynamic changes associated with benzodiazepine and alkyl beta-carboline-3-carboxylate binding to rat brain homogenates. Mol Pharmacol (1982) 0.75
Spectrophotometric assay for diphenylthiohydantoin in biological materials. Anal Biochem (1973) 0.75
Assessment of diabetogenic drug activity in the rat: 5,5-diphenyl-2-thiohydantoin. J Toxicol Environ Health (1977) 0.75
Effects of thiamine deficiency and octanoate administration, in vivo, on gluconeogenesis in rat kidney slices and on amino acid profile in rat liver. Proc Soc Exp Biol Med (1972) 0.75
Influence of 1,3-butanediol on blood glucose concentration and pancreatic insulin content of streptozotocin-diabetic rats. Fed Proc (1975) 0.75
1,3-Butanediol catabolism in the rat. Fed Proc (1975) 0.75
Correlation of systemic and developmental toxicities with chemical component classes of refinery streams. Fundam Appl Toxicol (1994) 0.75
Systemic toxicity from subchronic dermal exposure, chemical characterization, and dermal penetration of catalytically cracked clarified slurry oil. Toxicol Ind Health (1986) 0.75
Correlation of mutagenic potencies of various petroleum oils and oil coal tar mixtures with DNA adduct levels in vitro. Mutat Res (1997) 0.75
Effects of cations and anions on the binding of 3H-diazepam to rat brain. Proc Soc Exp Biol Med (1978) 0.75
Effects of 5,5'-diphenyl-2-thiohydantoin on respiration and oxidative phosphorylation of rat liver mitochondria. Chem Biol Interact (1975) 0.75
Effects of chronic acetylsalicylate administration on several nutritional and biochemical parameters in rats fed diets of varied thiamin content. Biochem Med (1973) 0.75
Estimation of the dermal carcinogenic activity of petroleum fractions using a modified Ames assay. Cell Biol Toxicol (1984) 0.75
Effect of clofibrate administration on several biochemical parameters of normal and thyroidectomized rats. Biochem Pharmacol (1977) 0.75
The effects of a polychlorinated biphenyl mixture (Aroclor 1254) on liver gluconeogenic enzymes of normal and alloxan-diabetic rats. Toxicology (1975) 0.75
Systemic toxicity of dermally applied crude oils in rats. J Toxicol Environ Health (1997) 0.75
Effects of SC-26096(2-methyl-3-oxo-2azabicyclo(2.2.2.)octan-6-exo-yl 5-(4-biphenylyl)-3-methyl valerate), a new hypolipidemic agent, on mitochondrial respiration and oxidative phosphorylation. Biochem Pharmacol (1974) 0.75
Predicting carcinogenicity of petroleum distillation fractions using a modified Salmonella mutagenicity assay. Cell Biol Toxicol (1986) 0.75
Cholecystokinin in vivo reduces binding to rat hypothalamic beta-adrenergic sites. Peptides (1984) 0.75
Safety evaluation of petroleum products using an in vitro eye irritation test battery. Toxicol In Vitro (1994) 0.75
Metabolism cage for carbon dioxide trapping studies. J Toxicol Environ Health (1977) 0.75
Systemic and developmental toxicity of dermally applied syntower bottoms in rats. Fundam Appl Toxicol (1997) 0.75
Percutaneous absorption of anthracene in the rat: comparison of in vivo and in vitro results. Toxicol Ind Health (1986) 0.75